TetraMem vs. Huang: Federal Circuit Dismisses ReRAM Patent Appeal in 143 Days

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

📋 Case Summary

Case Name Huang v. TetraMem, Inc.
Case Number 25-1878 (Fed. Cir.)
Court Federal Circuit, Appeal from N.D. Cal. (Underlying Case)
Duration June 24, 2025 – Nov 14, 2025 143 days
Outcome Appeal Dismissed – Voluntary Withdrawal
Patents at Issue
Accused Products TetraMem MX100, Analog-in-ReRAM product line

In a swift procedural conclusion, the U.S. Court of Appeals for the Federal Circuit dismissed the patent infringement appeal in Huang v. TetraMem, Inc., Case No. 25-1878, on November 14, 2025—just 143 days after filing. TetraMem, Inc., a developer of analog-in-memory computing technology, voluntarily moved to withdraw its own appeal under Federal Rule of Appellate Procedure 42(b), with each side bearing its own costs.

The case centered on U.S. Reissue Patent No. RE45,259E, tied to TetraMem’s MX100 chip and its broader Analog-in-ReRAM product line—an emerging class of resistive random-access memory (ReRAM) semiconductors that are central to next-generation AI inference hardware.

While the dismissal forecloses further appellate development, the case carries meaningful strategic lessons for patent counsel, IP managers, and R&D teams operating in the high-stakes analog-in-memory computing space. The voluntary exit from litigation—without prejudice on costs—signals considerations worth analyzing from both an IP portfolio and litigation risk management perspective.

Case Overview

The Parties

⚖️ Appellant (Originally Defendant)

U.S.-based semiconductor company focused on analog computing-in-memory solutions leveraging ReRAM (Resistive RAM) technology. Its products, including the MX100 chip, target AI hardware acceleration.

🛡️ Appellee (Originally Plaintiff, Pro Se)

The named defendant in the original district court action, who notably appeared pro se (representing himself) throughout the appellate proceedings.

The Patent at Issue

This case centered on a significant patent in the analog-in-memory computing space:

  • Patent: U.S. Reissue Patent No. RE45,259E (Application No. 13/355,449)
  • Technology Area: Analog resistive random-access memory (ReRAM) circuit architectures
  • Significance: Reissue patents undergo additional USPTO scrutiny, meaning the claims in RE45,259E were affirmatively broadened or corrected post-original issuance—a detail relevant to infringement scope analysis.

The Accused Products

The accused products—Analog-in-ReRAM and the TetraMem MX100—represent TetraMem’s core commercial offerings. Their involvement in litigation underscores how foundational IP disputes can directly threaten product-line viability and investor confidence in deep-tech hardware startups.

Legal Representation

TetraMem was represented by Daniel Noah Lerman of Herbert Smith Freehills Kramer (US) LLP, a global firm with a recognized IP litigation practice. Xiaohua Huang appeared to represent himself, as no opposing counsel is listed in the case record.

Litigation Timeline & Procedural History

Appeal Filed June 24, 2025
Motion to Dismiss Filed Filed before November 14, 2025
Appeal Dismissed November 14, 2025
Total Duration (Appellate) 143 days
Appellate Court U.S. Court of Appeals for the Federal Circuit

The appeal was filed on June 24, 2025, in the U.S. Court of Appeals for the Federal Circuit—the exclusive appellate forum for U.S. patent matters—placing it within the District of Columbia circuit geographically.

The 143-day lifecycle from filing to dismissal is notably brief by Federal Circuit standards, where fully briefed patent appeals routinely span 18–24 months. This compressed timeline reflects the procedural nature of the termination: TetraMem filed a voluntary dismissal motion (ECF No. 5-1) before full briefing was completed, and Huang filed no opposition.

No chief judge assignment is noted in the available case record. The absence of substantive briefing or oral argument means no merits ruling was issued—a critical distinction for practitioners assessing the case’s precedential weight.

The Verdict & Legal Analysis

Outcome

The Federal Circuit granted TetraMem’s motion to dismiss its own appeal pursuant to FRAP Rule 42(b), with the order directing that “each side shall bear its own costs.” The appeal is dismissed with no merits adjudication on infringement, validity, or damages.

No damages award, injunctive relief, or claim construction ruling was issued at the appellate level.

Verdict Cause Analysis

The underlying action was classified as an infringement action. However, because the dismissal is purely voluntary and procedural, no substantive findings on infringement of RE45,259E were made by the appellate court.

The strategic calculus behind TetraMem’s voluntary withdrawal is not detailed in the public record, but several recognized patterns in patent litigation inform the analysis:

  • Negotiated resolution: Voluntary dismissals under FRAP 42(b) with each side bearing costs frequently follow confidential settlement agreements, licensing arrangements, or business-level resolutions reached between parties—particularly where one party is an individual (Huang) rather than a corporate entity.
  • Litigation economics: Continuing a Federal Circuit appeal against a pro se defendant carries asymmetric cost risk, especially if the commercial objective (e.g., clarifying patent scope, obtaining injunction) had already been achieved at the district court level or through a parallel agreement.
  • Portfolio reassessment: ReRAM patent portfolios are evolving rapidly. Companies may recalibrate litigation positions as claim landscapes shift through continuation filings or inter partes review proceedings at the USPTO.

Legal Significance

Because no merits ruling was issued, Huang v. TetraMem creates no binding precedent on ReRAM patent claim construction, infringement standards, or validity of reissue patents in this technology space. However, the case’s existence on the Federal Circuit docket—and its resolution pattern—remains discoverable and citable as a procedural data point.

The involvement of a reissue patent (RE45,259E) is worth flagging for practitioners. Reissue patents are particularly vulnerable to intervening rights defenses under 35 U.S.C. § 252, which limits infringement liability for products made or used before the reissue. Any future assertion of RE45,259E will likely need to address this doctrine directly.

Strategic Takeaways

For Patent Holders: Voluntary dismissal under FRAP 42(b) preserves flexibility and avoids adverse appellate precedent. When litigation objectives are satisfied or commercial priorities shift, structured exits protect portfolio value.

For Accused Infringers: A pro se defendant who files no opposition and incurs no cost liability represents an outcome of particular note. Early, proactive engagement—even informally—can sometimes resolve disputes before significant appellate costs accumulate.

For R&D Teams: Products at the commercial core of a company (like the MX100) should be subject to rigorous freedom-to-operate (FTO) analysis, particularly where reissue patents are in play, as broadened claims can ensnare products designed around the original patent.

🔍

Developing ReRAM technology?

Check if your analog-in-memory design might infringe this or related patents.

Run FTO Check →

Industry & Competitive Implications

The analog-in-memory computing market—anchored by ReRAM, PCM, and MRAM technologies—is one of the most patent-contested frontiers in semiconductor IP. As AI inference workloads demand energy-efficient, high-throughput memory architectures, companies like TetraMem occupy a strategically sensitive position.

This case reflects a broader industry pattern: individual inventors and early-stage patent holders asserting foundational ReRAM IP against commercializing companies. Even where such disputes resolve quickly, the litigation signal affects investor perception, partnership negotiations, and product roadmap decisions.

For competitors and adjacent players in the ReRAM ecosystem—including fabless startups, DRAM incumbents exploring resistive memory transitions, and AI chip developers—this case reinforces the importance of:

  • Conducting proactive reissue patent monitoring through USPTO assignment and reissue databases
  • Establishing clear chain-of-title documentation for employee inventor assignments
  • Maintaining litigation reserves appropriate to the technology risk profile of core products

The involvement of Herbert Smith Freehills Kramer signals that TetraMem engaged sophisticated IP litigation counsel, suggesting the underlying dispute—while short-lived at the appellate level—was treated with appropriate seriousness.

Power Your Patent Strategy with Eureka IP

From novelty searches to patent drafting, Eureka’s AI-powered tools help you navigate the patent landscape with confidence.

⚠️ Freedom to Operate (FTO) Analysis

This case highlights critical IP risks in ReRAM technology. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific risks and implications from this litigation in the ReRAM space.

  • View related patents in analog-in-memory computing
  • See key players in ReRAM patenting
  • Understand claim scope of reissue patents
📊 View Patent Landscape
⚠️
High Risk Area

Analog ReRAM circuit architectures

📋
Key Patent

U.S. Reissue Patent No. RE45,259E

Outcome

Appeal voluntarily dismissed in 143 days

✍️

Filing a ReRAM patent?

Learn from this case. Use AI to draft stronger claims that can withstand litigation.

Try Patent Drafting →

✅ Key Takeaways

For Patent Attorneys & Litigators

FRAP 42(b) voluntary dismissal is a strategic tool to preserve flexibility and avoid adverse appellate precedent when litigation objectives shift.

Search related case law →

Reissue patents (35 U.S.C. § 251) carry unique risks under the intervening rights doctrine; counsel asserting them must anticipate § 252 defenses.

Explore precedents →

Pro se defendants present asymmetric cost and procedural dynamics that affect appellate strategy calculations.

Analyze litigation costs →

For IP Professionals

Monitor reissue patent activity in your technology sector for claim scope changes that could affect cleared products.

Track patent reissues →

This case represents an infringement action, not an IPR or validity challenge, suggesting the RE45,259E claims survived into litigation without a PTAB challenge being filed or disclosed.

Review patent validity reports →

For R&D Leaders

Core commercial products should undergo FTO review that specifically includes reissue and continuation patents, not only original grants.

Start FTO analysis for my product →

A 143-day dispute lifecycle can still disrupt product timelines, partner confidence, and capital raises—early IP clearance is cost-effective risk management.

Get IP risk assessment →

Frequently Asked Questions

What patent was involved in Huang v. TetraMem, Inc.?

The case involved U.S. Reissue Patent No. RE45,259E (Application No. 13/355,449), covering technology relevant to analog resistive random-access memory (ReRAM) architectures.

Why was the Federal Circuit appeal dismissed?

TetraMem, Inc. voluntarily moved to dismiss its own appeal under FRAP Rule 42(b). The court granted the motion, with each side bearing its own costs. No merits ruling was issued.

How does this case affect ReRAM patent litigation?

Because the appeal was dismissed without substantive ruling, it sets no binding precedent. However, it highlights the active IP assertion environment surrounding ReRAM technologies and the strategic use of voluntary dismissal in patent appeals.

Ready to Strengthen Your Patent Strategy?

Join thousands of IP professionals using Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.

⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.